Ketamine in post-stroke depression: a report of 2 cases
Ketamine may be a viable treatment option for patients with treatment-resistant post-stroke depression. Further research is warranted to better understand the efficacy and safety of ketamine in this specific patient population.
Authors
- Adam Włodarczyk (ORCID: https://orcid.org/0000-0001-8549-254X)
- Joanna Szarmach (ORCID: https://orcid.org/0000-0002-7645-4821)
- Wiesław Jerzy Cubała (ORCID: https://orcid.org/0000-0001-6343-8454)
- Jakub Słupski (ORCID: https://orcid.org/0000-0002-4579-0208)
- D Milewska
Institutions
- Gdańsk Medical University (PL)
Publication Details
- Journal
- Frontiers in Psychiatry
- Published
- 2025-12-04
- DOI
- https://doi.org/10.3389/fpsyt.2025.1680687
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Agencja Badań Medycznych